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doi:10.1016/j.jprot.2011.06.018A B S T R A C TKeywords: The following report provides an overview of the discussions and outcome of the EuPA
General Council meeting that took place in Estoril 20–21 October 2010. During the annual
meeting future policy and action plans in a variety of areas are decided. Several important
points were decided upon during this meeting including the expansion of the EuPA
Executive Committee by introducing a new EuPA committee – EuPA Developments – that
will initially spearhead activities in standardisation, imaging ms and biobanking. The EuPA
General Council also invited Russia as its 17th member. More details about these and
additional activities are presented in the article.
© 2011 Published by Elsevier B.V.EuPA
Proteomics1. Expanding EuPA's activities and
increasing proficiency1.1. A foreword on EuPA
The representatives of the 17 European national proteomics
societies met up in Estoril at the 7th Meeting of the General
Council of the European Proteomics Association (EuPA).89.
. Corthals).
et al, The transition of
hed by Elsevier B.V.Since its inception 7 years ago EuPA has established itself
as a leading regional organisational body advancing directions
and interests of the 17 independent countries it represents.
The General Council, where each society is equally repre-
sented, is EuPA's governing body. During the General Council
meetings important directions and decisions for Eu-proteomics
are debated, voted upon and ratified.
Since its inception EuPA has grown. Initially, the regional
aspect and its organisational structure and operations led tothe European Proteomics Association into the future, J Prot
2 J O U R N A L O F P R O T E O M I C S X X ( 2 0 1 1 ) X X X – X X Xthe wider recognition of EuPA. This in turn has led to
expanded input, further developments and increased mem-
bership participation over the years. More recently EuPA has
become involved as the regional coordinating body of various
Eu-wide activities, impacting on many scientific careers and
developments. Thus, the gathering and operation of the
EuPA's General Council has an impact on European science
at large. Other organisations such as the European Commis-
sion and professional international bodies such as HUPO
have now also recognised EuPA. Through the membership of
the constituent national societies, the EuPA represents several
thousand proteomic scientists working in Europe, as well as
visiting scientists from all over the world working in Europe.
Therefore, decisionsmade by the General Council effect future
developments and directions. Because of this, it has become
an important and exciting activity to gather, discuss and
decide points that have the potential to advance proteomics
regionally.
1.2. Estoril milestones
One of the important points on the agenda for the Estoril
meeting focussed on a new structure and activities of the
Executive Committee. The members of the Executive Com-
mittee of EuPA had proposed that to move EuPA forward,
timely and reinvigorated policies and strategies were required
to maintain a positive impact on proteomics in Europe. The
following points are main outcomes of the General Council
meeting:
A. The General Council elected Jean-Charles Sanchez as the
next EuPA Vice President, and György Marko-Varga as the
next EuPA President. The General Council also decided on
the launch of a new fifth committee EuPA Developments thatFig. 1 – The new EuPA structure: five committees w
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(2011), doi:10.1016/j.jprot.2011.06.018nowcomprises threenewsections (more below). The leaders
of each section will be responsible to develop these new
initiatives and invite members into the respective sections.
The new structure of the EuPA is depicted in Fig. 1.
B. The central role and key future function of the funding
committee was also discussed. The Executive Committee
presented aplanwhere the future of the funding committee
plays a central role, due to the increase in EuPA activities.
Therefore, the funding committee will soon require
more resources and attention. To meet these tasks, David
O'Connor, Marius Ueffing and Peter Verhaert were elected
as new members within the Funding Committee.
C. The EuPA General Council also invited Russia as its 17th
member. Alexander Archakov, the president of the Russian
Human Proteome Organization (RHUPO) gave a presenta-
tion of the Russian Proteomics organisation and activities.
Details about their activities can be found via our web site.
• EuPA is forming its strategic future directives where the
key considerations in building this strategywere defined.
The salient points emerging from the discussions were
that i) EuPA supports its national proteomics societies in
the best way, and ii) the strategy should position EuPA
where it plays a key global role in regional and global
proteomics initiatives.2. Activities of EuPA's committee in 2009/10
2.1. The EuPA/HUPO committee
The liaison committee between EuPA and HUPO has played its
triple role, i.e. i) transferring information from HUPO to EuPA
as smoothly and as fast as possible, ii) trying to push forwardith the respective members of each committee.
the European Proteomics Association into the future, J Prot
Table 1 – The EuPA annual congresses: joint HUPO
congresses are scheduled every 3 years.
Year Location Organisations
2007 Valencia, Spain EuPA
2008 Amsterdam HUPO/EuPA
2009 Stockholm, Sweden EuPA
2010 Estoril, Portugal EuPA
2011 Geneva, Switzerland HUPO/EuPA
2012 Glasgow, Scotland EuPA
2013 St. Malo, France EuPA
2014 Madrid, Spain HUPO/EuPA
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iii) when available, coordinating HUPO and EuPA actions.
The most important actions have taken place in the latter
two aspects. One example is the tutorial programme, for
which the EuPA/HUPO committee has coordinated interests
between EuPA and HUPO, and to foster an active participa-
tion of the major proteomics journals, including Journal of
Proteomics. The programme is now under way and the first
tutorial papers should appear in 2011.
There are two other examples worth mentioning. The first
one is the gradual opening of HUPO to non-human, non-
mammalian proteomics, something that EuPA has promoted
since its beginning. The second example is the representation
of the regional proteomic societies (including EuPA of course)
in the HUPO board of directors, via directors nominated
directly by each regional society. This latter action is not
implemented yet, but should be implemented in 2012.
Thus, the EuPA/HUPO committee is happy to note that both
EuPA as a body and its ideas and vision are better taken
into account in HUPO's vision and operations.
2.2. EuPA CCC
TheCongressandCommunicationcommitteehasbeenengaged
in a successful launch of the EuPA Newsletter. So far four issues
have been published, where the members of the 17 national
societies, and others, can follow the events andprogressesmade
as well as future planning of the activities (www.EuPA.org).
The last issue of the EuPA bulletin has just been released. It
contains the message from the President and EuPA latest news,
information from the Russian proteome society, meeting re-
ports, information from the Journal of Proteomics, and other
information from the proteomics world. The fifth issue is
under construction and will be published shortly.
The oral and poster presentations of the 3rd EuPA Congress
(2009) were published as short manuscripts [1], and are also
posted in the EuPA database that can be accessed from the
EuPA homepage (www.EuPA.org). In addition, a special issue
of the Journal of Proteomics came out early in 2010 [2] with
manuscripts from the EuPA Congress in Stockholm. The short
papers from the 4th EuPA Congress in Estoril recently, were
also published as a proceedings issue [3] in 2010, and a call for
a special issue in 2011 is under development. Papers for the
Estoril EuPA Congress will be found in this journal during the
course of 2011.
2.2.1. EuPA and HUPO/EuPA congresses
The CCC has an elaborate document concerning the “Rights
and duties for the endorsement of the EuPA Annual Scientific
Meeting”. This document is the basis for the selection of
national proteomics society candidates. In Estoril the EuPA
General Council made decisions for the venues for the St. Malo
EuPA 2013 Congress, France, and the Madrid HUPO/EuPA 2014
Congress, Spain (Fig. 2). The past and the forthcoming EuPA
congresses are presented in Table 1.
The HUPO–EuPA Congress in Geneva, 2011 will hold a
workshop on non-human oriented proteomics research that
will take place, September 4th, 2011. The main topics will be
plant, animal and microorganism proteomics. EuPA will
provide up to 40 bursaries for students in a 50% reduction ofPlease cite this article as: Corthals GL, et al, The transition of
(2011), doi:10.1016/j.jprot.2011.06.018the fee. In addition a presentation on EuPA's achievements
and plans will be organised.
2.3. EuPA education — Europe's knowledge network
A well-documented list of courses and activities has been
established in recent years. For a complete list of these
activities we invite the reader to view the events and material
listed on the EuPA website. Further information about the
strategic development of educational plans is listed below.
The Education Committee has established a wide range of
activities that comprises basic courses, advanced courses,
support for summer and winter schools, workshops, education
daysat EuPAmeetings, the tutorial programme (in collaboration
with HUPO), and there is teaching material that is publicly
available from the EuPA website. The collected activities of the
Education Committee have elevated EuPA to a positionwhere it
has becomemore than a network of scientists. These enhanced
activities are leading us towards becoming a pan-European
knowledge network. Indeed these are exciting developments,
and they are critically dependent on the resources sustained
over time, so that material is updated, and knowledge dis-
semination reaches out to all corners and scientists in need.
In the near future EuPA will release call for funding to
support a variety of high quality courses and summer/winter
schools in proteomics. There are four basic courses for which
teachingmaterial existsandmaybeused: gel-basedproteomics,
MS-based proteomics, chromatography-based proteomics, and
bioinformatics for proteomics. Plans for new courses that cover
proteomics-basics not already listed will be welcomed. For the
advanced courses our objective is to disseminate expertise in
technically advanced or novel methods and emerging tech-
niques to a broad number of laboratories. The primary objective
is to ensure that participants can implement newly learned
methods and techniques in their own laboratories. A new
activity we will establish is the EuPA sponsored summer and
winter schools, which aim to provide an international forum for
the presentation and discussion of frontier research in all
aspects of proteomesciences. Formore information about these
exciting activities please visit the EuPA website.
One way to improve education is through the provision
of high quality peer-reviewed teaching material. To this
end, the International Proteomics Tutorial Programme has
been launched (http://www.proteomicstutorials.org). It is a
cooperation between the four main journals that publish
in the field of proteomics on the one hand, and HUPO. EuPAthe European Proteomics Association into the future, J Prot
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programme is being organised by Peter James, Kazuyuki
Nakamura and Thierry Rabilloud. A set of 48 tutorial articles
accompanied by a PowerPoint lecture are being commissioned
and the series will be launched in the summer of 2011.
2.4. EuPA developments
The new EuPA committee, “New Developments” was intro-
duced in Estoril by the Executive Council and approved by the
General Council. The aim of this new committee is to promote
emerging research areas and activities that will be important
in the near future and that will give EuPA as an organisation
an operational role, based upon the activities within the
three respective sections. Three sections selected for current
development are standardisation, imagingmass spectrometry
and biobanking which will be briefly discussed below.
2.4.1. Standardisation
Mass spectrometry (MS) based proteomics has evolved substan-
tially over the past decade and a new scenario can be visualised
with major improvements in instrumentation, novel (targeted)
methodologies, comprehensive sequence database, auto-
mation and reports with identification and quantifications of
thousands of proteins. In particular the speed and content,
automation of scoring and subsequent reporting require
robust quality control (QC) and standardisation approaches
to attain appropriate reliability of the technology applied.
ABRF, HUPO and ProteoRed [1–5] have developed test
standards to evaluate end-to-end quality control for proteo-
mics. A detailed effort towards systematic QC has been
undertaken by the National Cancer Institute (NCI) via its
large-scale Clinical Proteomic Technology Assessment for
Cancer (CPTAC) project [6,7]. Clearly these efforts underscoreFig. 2 – Photograph of the EuPA General Council members and pa
Estoril, Portugal, 2011.
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virtue of their findings have defined actions for improving the
quality of data and evaluating the robustness, repeatability
and reproducibility of defined proteomics workflows [8]. A
ProteoRed proposal for 2011 exists for targeted quantitative
proteomics study where SRM, pseudo SRM and not targeted
approaches will be evaluated. Details for taking part in this
study (called PME-7) can be obtained from www.proteored.org
and www.EuPA.org.
2.4.2. Imaging mass spectrometry
It is the objective of the EuPA imaging mass spectrometry
group to align and collaborate with already existing expert
groups, such as the European imaging mass spectrometry
consortium. As the imaging mass spectrometry field is a
multidisciplinary research field it bridges scientists from the
mass spectrometry field with pathologists, biologists, chem-
ists, biostatisticians and bioinformation.
The mission and goals of this new section will be to
collaborate, share expert experience, as well as to give
workshops and tutorials. In more detail, the aim is to dis-
seminate methods, develop synergies between its members,
develop standardised methods and tools, test applicability,
capacities and limitations for a variety of different diseases,
provide resources, training and guidelines, and to establish
imaging mass spectrometry amongst a broader scientific
community. The aim is to build and strengthen synergies
between the connections already developed within European
imaging mass spectrometry research laboratories.
2.4.3. Biobanking
TIME magazine highlighted biobanking as one of “10 Ideas
Changing the World Right Now”. Biobanking is rapidly
growing and thriving to change approaches to target finding,rticipants at the 4th EuPA Scientific Meeting that took place in
the European Proteomics Association into the future, J Prot
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a key driver for the next generation biomarker and drug
discovery, including developments within biobank initiatives
that are quickly increasing globally. Another area is the health
care area that is in great need for early diagnosis. Biobanks
that hold archived clinical material are to be used for the
discovery of biomarkers for disease grading and indications,
along with epidemiological studies.3. In conclusion
Most importantly there will be significant time set aside to
discuss in some detail how we can shape EuPA's future over
the next period to maximise its influence and visibility at the
European and world-wide level. A new Operating Committee
of the Executive Committee, Chaired by György Marko-Varga,
has been formed to take these initiatives forward. As EuPA
develops its activities, where researchdrivenprojects has been
assigned, such as the three in “NewDevelopments”, we will be
looking at expanding our achievements and deliveries. Many
of these are expected to be published and presented in the
Journal of Proteomics, which is the EuPA proteomics research
journal.Please cite this article as: Corthals GL, et al, The transition of
(2011), doi:10.1016/j.jprot.2011.06.018R E F E R E N C E S
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